Previous wound treatments included daily dressing changes with Medihoney™, Maxisorb™, alginate, Optifoam™ Ag, and essential oils. Wound cultures and nutritional assessments were obtained during the initial consultation. A treatment plan was developed to include nutritional support with supplements and use of EHOB® pressure reduction bed and chair surfaces. Wound dressings were changed daily with Acquacel™ Ag, then DermaWound® with alginate packing and foam dressing until NPWT was available for Wound A, left sacrum, and Wound B, midline sacrum.
Wounds were treated with Aquacel™ Ag and foam dressing until DermaWound® was available.
||50% slough and 50% granulation tissue, periwound intact. Wound culture obtained.
||50% slough and 50% granulation tissue, no bone exposed, bone easily palpated under tissue, periwound intact.
Wound was treated with DermaWound®, alginate packing and foam dressing twice daily. Linizoid was cost prohibitive because it was not on patient drug formulary, therefore, initiation of NPWT with Simultaneous Irrigation™ Technology anticipated in one week
||Presented with wound culture positive for enterococcus faecalis.
||Presented with 60% slough and 40% granulation tissue, no bone exposure, copious serosanguinous drainage and negative wound culture.
NPWT with Simultaneous Irrigation™ Technology initiated